IL206045A0
(en )
2010-11-30
Carbamoyl compounds as dgat1 inhibitors 190
AU2007245059A1
(en )
2007-11-08
New compounds
ZA201000829B
(en )
2010-12-29
Oxadiazole- and oxazole-substituted benzamidazole-and indole-derivatives as dgat1 inhibitors
AU2007267535A8
(en )
2011-06-09
Aziridinyl-epothilone compounds
AU2008246443A8
(en )
2010-01-07
1, 3-dihydroimidazole- 2 -thione derivatives as inhibitors of dopamine-beta-hydroxylase
EP2152726B8
(en )
2015-02-18
Analgesic compounds
AU2007234746A8
(en )
2008-07-17
Naphthalenedione compounds
ZA200710338B
(en )
2008-11-26
Oxydiazole derivatives as DGAT inhibitors
HK1148285A
(en )
2011-09-02
Carbamoyl compounds as dgat1 inhibitors 190
EP1998776A4
(en )
2009-07-08
Pyridine-containing macroheterocylic compounds as kinase inhibitors
HK1142316A
(en )
2010-12-03
Oxadiazole- and oxazole-substituted benzimidazole- and indole-derivatives as dgat1 inhibitors
HK1143036A
(en )
2010-12-24
Kinase inhibitor compounds
HK1141792A
(en )
2010-11-19
New compounds 892
HK1162493A
(en )
2012-08-31
New compounds 578
HK1133371A
(en )
2010-03-26
11beta-hsd1 active compounds
AU2007904732A0
(en )
2007-09-13
Compounds
AU2007906387A0
(en )
2007-12-06
Retrometabolic compounds
AU2007900027A0
(en )
2007-01-18
Heterocyclic compounds
HK1136281A
(en )
2010-06-25
Chemical compounds 637: pyridopyrimidinediones as pde4 inhibitors
HK1134499A
(en )
2010-04-30
Pdgfrbeta-specific inhibitors
AU2007100045A4
(en )
2007-03-01
Kuvva 2
AU2007100060A4
(en )
2007-03-08
Kuvva 1
HK1125373A
(en )
2009-08-07
Novel compounds
AU2006902215A0
(en )
2006-05-11
Profluorescent nitroxide compounds
AU2006906153A0
(en )
2006-11-16
Compounds